AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 5th, 2018 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • California
WHEREAS, this Amended and Restated Employment Agreement (the “Agreement”) is entered into on January 14, 2018 and effective as of January 1, 2018 (the “Effective Date”) by and between Fate Therapeutics, Inc. (the “Company”) and J. Scott Wolchko (the “Executive”) as President and Chief Executive Officer of the Company (“CEO”); and
